Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Effect on CNS Glucose Metabolism during Hyperglycemia
NCT01185119Phase 3Completed
- Sponsor
- Aarhus University
- Start
- Jun 2010
- Primary completion
- Dec 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Glucagon-like peptide 1(7-36)-amide in type 2 diabetes mellitus (T2DM), stroke and myocardial infarction (MI), sponsored by Aarhus University. Primary endpoint: Steady glucose metabolism in the brain during hyperglycemia at 1 day. Started Jun 2010; status: completed.
02
Drugs
Glucagon-like peptide 1(7-36)-amide
03
Conditions
type 2 diabetes mellitus (T2DM)strokemyocardial infarction (MI)
Beyond the preview
Go deeper on NCT01185119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185119.